Neurotrophins, VEGF and matrix metalloproteinases: new markers or causative factors of metabolic syndrome components?

Ewa Błaszczyk; Aneta Gawlik

Pełna treść

3/2016 vol. 22

Artykuł przeglądowy

Neurotrofiny, VEFG i metaloproteinazy macierzowe: nowe markery czy czynniki sprawcze składowych zespołu metabolicznego?

Ewa Błaszczyk

,

Aneta Gawlik

Data publikacji online: 2017/06/18

Plik artykułu

a_36600.pdf

AMA

Błaszczyk E, Gawlik A. Neurotrophins, VEGF and matrix metalloproteinases: new markers or causative factors of metabolic syndrome components?. Pediatric Endocrinology Diabetes and Metabolism. 2016;22(3).

APA

Błaszczyk, E., & Gawlik, A. (2016). Neurotrophins, VEGF and matrix metalloproteinases: new markers or causative factors of metabolic syndrome components?. Pediatric Endocrinology Diabetes and Metabolism, 22(3).

Chicago

Błaszczyk, Ewa, and Aneta Gawlik. 2016. "Neurotrophins, VEGF and matrix metalloproteinases: new markers or causative factors of metabolic syndrome components?". Pediatric Endocrinology Diabetes and Metabolism 22 (3).

Harvard

Błaszczyk, E., and Gawlik, A. (2016). Neurotrophins, VEGF and matrix metalloproteinases: new markers or causative factors of metabolic syndrome components?. Pediatric Endocrinology Diabetes and Metabolism, 22(3).

MLA

Błaszczyk, Ewa et al. "Neurotrophins, VEGF and matrix metalloproteinases: new markers or causative factors of metabolic syndrome components?." Pediatric Endocrinology Diabetes and Metabolism, vol. 22, no. 3, 2016.

Vancouver

Błaszczyk E, Gawlik A. Neurotrophins, VEGF and matrix metalloproteinases: new markers or causative factors of metabolic syndrome components?. Pediatric Endocrinology Diabetes and Metabolism. 2016;22(3).

ZGŁASZANIE PRAC

Udostępnij

Zintergrowane z

Zasady redakcyjne

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications